Skip to main content
Top

Breast Cancer

Issue 4/2012

Content (17 Articles)

Open Access Review Article

Reproductive history and breast cancer risk

Shunzo Kobayashi, Hiroshi Sugiura, Yoshiaki Ando, Norio Shiraki, Takeshi Yanagi, Hiroko Yamashita, Tatsuya Toyama

Original Article

Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer

Hideaki Tokiniwa, Jun Horiguchi, Daisuke Takata, Mami Kikuchi, Nana Rokutanda, Rin Nagaoka, Ayako Sato, Hiroki Odawara, Katsunori Tozuka, Tetsunari Oyama, Izumi Takeyoshi

Original Article

Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of Japan

Yasuaki Sagara, Yoshihiko Kamada, Yutaka Yamamoto, Maki Tanaka, Makoto Kubo, Rin Yamaguchi, Reiki Nishimura, Shoshu Mitsuyama

Original Article

Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer

Peifen Fu, Mutsuko Ibusuki, Yutaka Yamamoto, Satoko Yamamoto, Saori Fujiwara, Keiichi Murakami, Shusen Zheng, Hirotaka Iwase

Original Article

A lower dose of docetaxel at 60 mg/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer

Mari Hosonaga, Yoshinori Ito, Nahomi Tokudome, Shunji Takahashi, Takuji Iwase, Kiyohiko Hatake

Original Article

Long-term gemcitabine administration in heavily pretreated Japanese patients with metastatic breast cancer: additional safety analysis of a phase II study

Shintaro Takao, Yutaka Tokuda, Toshiaki Saeki, Jumpei Funai, Masami Ishii, Shigemitsu Takashima

Original Article

Ultrasonographic findings of invasive micropapillary carcinoma of the breast: correlation between internal echogenicity and histological findings

Kumiko Kamitani, Takeshi Kamitani, Minoru Ono, Satoshi Toyoshima, Shoshu Mitsuyama

Original Article

Phase I/II study of intraoperative radiotherapy for early breast cancer in Japan

Masataka Sawaki, Shigenori Sato, Sumiyo Noda, Ai Idota, Hiroki Uchida, Nobuyuki Tsunoda, Toyone Kikumori, Yuichi Aoyama, Shunichi Ishihara, Yoshiyuki Itoh, Tsuneo Imai

Case Report

A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast

Kae Okoshi, Tatsuyoshi Saiga, Shigeo Hisamori, Keiko Iwaisako, Hisato Kobayashi, Hiroki Ogawa

Case Report

Pure mucinous carcinoma with axillary lymph node metastasis in a male breast

Dimitrios M. Dragoumis, Anthoula S. Assimaki, Aris P. Tsiftsoglou

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine